Vimarsana
Biggest News Aggregation in the World

Kala Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kala Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kala Pharmaceutical Today - Breaking & Trending Today

Five things for pharma marketers to know: Thursday, December 29, 2022 - Vimarsana News

Five things for pharma marketers to know: Thursday, December 29, 2022

FDA accepts Kala Pharmaceutical’s investigational new drug application for KPI-012; Supreme Court keeps Title 42 in effect.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Expected to Post Quarterly Sales of $3.06 Million - Vimarsana News

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Expected to Post Quarterly Sales of $3.06 Million

Analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to post $3.06 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Kala Pharmaceuticals’ earnings. The highest sales estimate is $4.20 million and the lowest is $1.76 million. Kala Pharmaceuticals posted sales of $3.05 million during the […]

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Expected to Post Earnings of -$0.38 Per Share - Vimarsana News

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Expected to Post Earnings of -$0.38 Per Share

Wall Street analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to report earnings of ($0.38) per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Kala Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.43). Kala Pharmaceuticals […]

$3.09 Million in Sales Expected for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) This Quarter - Vimarsana News

$3.09 Million in Sales Expected for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) This Quarter

Wall Street brokerages predict that Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) will announce sales of $3.09 million for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Kala Pharmaceuticals’ earnings, with estimates ranging from $2.04 million to $5.00 million. Kala Pharmaceuticals reported sales of $3.27 million during the same […]

Zacks: Brokerages Expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Will Post Quarterly Sales of $3.38 Million - Vimarsana News

Zacks: Brokerages Expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Will Post Quarterly Sales of $3.38 Million

Analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to announce sales of $3.38 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Kala Pharmaceuticals’ earnings. The highest sales estimate is $3.50 million and the lowest is $3.24 million. Kala Pharmaceuticals posted sales of $2.24 million during the […]